ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.22M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−176.00
Price / share
$542.73
Trade value
$95.52K
% of position
Common Stock
Shares
−744.00
Price / share
$543.76
Trade value
$404.56K
% of position
Common Stock
Shares
−2.10K
Price / share
$544.82
Trade value
$1.14M
% of position
Common Stock
Shares
−493.00
Price / share
$545.85
Trade value
$269.10K
% of position
Common Stock
Shares
−629.00
Price / share
$546.94
Trade value
$344.03K
% of position
Common Stock
Shares
−387.00
Price / share
$548.18
Trade value
$212.14K
% of position
Common Stock
Shares
−1.17K
Price / share
$549.13
Trade value
$644.13K
% of position
Common Stock
Shares
−874.00
Price / share
$550.14
Trade value
$480.82K
% of position
Common Stock
Shares
−486.00
Price / share
$551.09
Trade value
$267.83K
% of position
Common Stock
Shares
−440.00
Price / share
$552.29
Trade value
$243.01K
% of position
Common Stock
Shares
−185.00
Price / share
$553.70
Trade value
$102.43K
% of position
Common Stock
Shares
−485.00
Price / share
$554.51
Trade value
$268.94K
% of position
Common Stock
Shares
−930.00
Price / share
$555.77
Trade value
$516.87K
% of position
Common Stock
Shares
−400.00
Price / share
$556.48
Trade value
$222.59K
% of position
Net shares
+0.00
Net value
-$4.10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/7/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −176.00 | $542.73 | $95.52K | 0.1% | 333.94K | 333.77K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −744.00 | $543.76 | $404.56K | 0.2% | 333.77K | 333.02K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −2.10K | $544.82 | $1.14M | 0.6% | 333.02K | 330.93K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −493.00 | $545.85 | $269.10K | 0.1% | 330.93K | 330.43K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −629.00 | $546.94 | $344.03K | 0.2% | 330.43K | 329.80K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −387.00 | $548.18 | $212.14K | 0.1% | 329.80K | 329.42K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −1.17K | $549.13 | $644.13K | 0.4% | 329.42K | 328.24K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −874.00 | $550.14 | $480.82K | 0.3% | 328.24K | 327.37K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −486.00 | $551.09 | $267.83K | 0.1% | 327.37K | 326.88K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −440.00 | $552.29 | $243.01K | 0.1% | 326.88K | 326.44K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −185.00 | $553.70 | $102.43K | 0.1% | 326.44K | 326.26K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −485.00 | $554.51 | $268.94K | 0.1% | 326.26K | 325.77K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −930.00 | $555.77 | $516.87K | 0.3% | 325.77K | 324.84K |
| Common Stock Indirect | 10/7/2026 | S · Sale | −400.00 | $556.48 | $222.59K | 0.1% | 324.84K | 324.44K |
| Total | +0.00 | -$4.10M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
280.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/7/2026 | M · Option Exercise | −9.50K | 117.76 | — | 280.91K |
Common Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 45.60K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 8.90K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |